Abstract
In a long-term study with 3% guanethidine and 0.5% adrenaline in one eye drop (GA) the combined results of patients with primary open angle glaucoma (POAG) and glaucoma suspects showed a biphasic response in intraocular pressure (IOP). The hypertensive phase peaked 3 hrs after administration (at noon) and reached a maximum of 3.5 mm Hg (p < 0.005) above the hypotensive phase. It is reported in the literature that during office hours untreated glaucoma patients show a peak near noon, suggesting that the initial increase in IOP may be the normal IOP pattern.
When the data of untreated patients with POAG and glaucoma suspects were separated, an increase in IOP around noon in the first group and a decrease around noon in the glaucoma suspects was found. However, during GA-treatment both groups showed a hypertensive response at noon (3 hrs). In addition, the highest IOP's in daycurves were timed during and without GA. It was shown that during GA there was a shift in the incidence of the highest IOP's towards noon (from 8.3% to 73.2% for patients with suspected glaucoma and from 32% to 63.6% for those with POAG).
It was therefore concluded that GA induces a characteristic biphasic IOP pattern in patients with POAG as well as in glaucoma suspects. Also, glaucoma suspects may have higher peak pressures more frequently than POAG patients. Furthermore, the study showed that during office hours untreated glaucoma suspects have daycurves with higher pressures in the morning while patients with POAG have higher pressures near noon.
Similar content being viewed by others
References
Bitran, D. Evaluacion de la curve de tension diaria. Arch. Chil. Oftal. 25: 32–39 (1968). Abstract Zbl. ges. Ophthal. 103: 125 (1970).
Drance, S.M. The significance of the diurnal tension in variations in normal and glaucomatous eyes. Arch. Ophthal. 64: 494–501 (1960).
Hoyng, Ph. F. J. & Dake, C. L. The combination of guanethidine 3% and adrenaline 0.5% in one eye drop (g-a) in glaucoma treatment. Brit. J. Ophthal. 63: 56–62 (1979).
Jones, D. E. P., Norton, D. A. & Davies, D. J. G. Control of glaucoma by reduced dosage guanethidine-adrenaline formulations. Brit. J. Ophthal. 63: 813–816 (1979).
Lamble, J. W. The effect of topically applied guanethidine sulphate on the pupil and tension responses of the rabbit eye to (-) adrenaline bitartrate. Exp. Eye Res. 19: 79–89 (1974).
Langham, M. E. & Krieglstein, G. K. The biphasic intra-ocular pressures response of rabbits to epinephrine. Invest. Ophthal. 15: 119–127 (1976).
Langham, M.E. & Palewicz, K. The pupillary, the intra-ocular pressure and the vasomotor responses to nor-adrenaline in rabbits. J. Physiol. 267: 339–355 (1977).
Leydhecker, W. Glaukom. Ein Handbuch. Zweite völlig neubearbeitete Auflage. Seite 410–415. Springer Verlag, Berlin - Heidelberg - New York, (1973).
Unger, W. G. & Hammond, B. R. Nor-adrenaline - induced inflammation in the sympathectomised rabbit eye. IRCS Med. Sci. 5: 563 (1977).
Urner-Bloch, U., Bucheli, J., Eltz, H., Gloor, J.B. & Aeschlimann, J. Clinical trials of various glaucoma drugs acting on the adrenergic system. Klin. Mbl. Augenheilk. 176: 555–558 (1980).
Waitzman, M. B. & Woods, W. D. Effects of prostaglandins, norepinephrine on intraocular pressure and pupil size in rabbits following cervical ganglionectomy. Invest. Ophthal. 18: 52–60 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoyng, P.F.J. Verification of the biphasic response in intraocular pressure during treatment of glaucoma patients with 3% guanethidine and 0.5% adrenaline. Doc Ophthalmol 51, 161–173 (1981). https://doi.org/10.1007/BF00140885
Issue Date:
DOI: https://doi.org/10.1007/BF00140885